Literature DB >> 12682849

Increased risk of bronchopulmonary dysplasia and increased mortality in very preterm infants being small for gestational age.

Irwin Reiss1, Eva Landmann, Matthias Heckmann, Björn Misselwitz, Ludwig Gortner.   

Abstract

OBJECTIVE: The objective was to evaluate the impact of being born small for gestational age (SGA) on neonatal mortality and neonatal pulmonary morbidity in preterm infants <32 weeks of gestation.
METHODS: We reviewed the data reported prospectively to the quality assurance program of the Federal State of Hesse, Germany, from 1990 to 1996 of infants <32 weeks of gestation. SGA was defined as birth weight below the 10th percentile. Mann Whitney U tests were used to compare continuous variables and Fisher's exact tests to analyze differences in dichotomous variables between preterm SGA neonates and preterms born appropriate for gestational age (AGA). The effect of SGA and other potential risk factors for neonatal death and bronchopulmonary dysplasia, i.e., requiring a fraction of inspired oxygen >0.21 at day 28, was tested by multivariable analyses.
RESULTS: Data from 1,365 infants were analyzed. One hundred and eighty-three neonates were SGA (mean [SD] birth weight 789 [179] g; mean [SD] gestational age 28.9 [1.7] weeks) and 1,182 were AGA (mean [SD] birth weight 1,260 [348] g; mean [SD] gestational age 28.8 [2.1] weeks). Neonatal mortality and the rate of bronchopulmonary dysplasia were significantly higher in SGA neonates (23 vs. 11% and 28 vs. 14%, respectively). There was a statistically significant association of SGA with neonatal death (odds ratio [OR] = 4.54, 95% confidence interval [CI] 2.56, 8.04) and bronchopulmonary dysplasia (OR=3.80, 95% CI 2.11, 6.84).
CONCLUSION: SGA neonates below 32 weeks gestation are a high-risk group regarding neonatal mortality and neonatal pulmonary morbidity.

Entities:  

Mesh:

Year:  2003        PMID: 12682849     DOI: 10.1007/s00404-003-0486-9

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  33 in total

1.  Fetal origins of neonatal lung disease: understanding the pathogenesis of bronchopulmonary dysplasia.

Authors:  Karen K Mestan; Robin H Steinhorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

Review 2.  Epigenetics and the developmental origins of lung disease.

Authors:  Lisa A Joss-Moore; Kurt H Albertine; Robert H Lane
Journal:  Mol Genet Metab       Date:  2011-07-23       Impact factor: 4.797

Review 3.  Chronic lung disease in the preterm infant. Lessons learned from animal models.

Authors:  Anne Hilgendorff; Irwin Reiss; Harald Ehrhardt; Oliver Eickelberg; Cristina M Alvira
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

4.  Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia.

Authors:  Jen-Ruey Tang; S Ananth Karumanchi; Gregory Seedorf; Neil Markham; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-14       Impact factor: 5.464

5.  Prenatal predictors of mortality in very preterm infants cared for in the Australian and New Zealand Neonatal Network.

Authors:  N Evans; J Hutchinson; J M Simpson; D Donoghue; B Darlow; D Henderson-Smart
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-07-28       Impact factor: 5.747

6.  IUGR decreases elastin mRNA expression in the developing rat lung and alters elastin content and lung compliance in the mature rat lung.

Authors:  Lisa A Joss-Moore; Yan Wang; Xing Yu; Michael S Campbell; Christopher W Callaway; Robert A McKnight; Albert Wint; Mar Janna Dahl; Randal O Dull; Kurt H Albertine; Robert H Lane
Journal:  Physiol Genomics       Date:  2011-03-01       Impact factor: 3.107

7.  Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep.

Authors:  Paul J Rozance; Gregory J Seedorf; Alicia Brown; Gates Roe; Meghan C O'Meara; Jason Gien; Jen-Ruey Tang; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-26       Impact factor: 5.464

Review 8.  Can We Understand the Pathobiology of Bronchopulmonary Dysplasia?

Authors:  Cristina M Alvira; Rory E Morty
Journal:  J Pediatr       Date:  2017-11       Impact factor: 4.406

9.  Congenital heart disease in low-birth-weight infants: effects of small for gestational age (SGA) status and maturity on postoperative outcomes.

Authors:  Daniel Wei; Colleen Azen; Shazia Bhombal; Laura Hastings; Lisa Paquette
Journal:  Pediatr Cardiol       Date:  2014-07-06       Impact factor: 1.655

10.  Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation.

Authors:  Carl Bose; Linda J Van Marter; Matthew Laughon; T Michael O'Shea; Elizabeth N Allred; Padmani Karna; Richard A Ehrenkranz; Kim Boggess; Alan Leviton
Journal:  Pediatrics       Date:  2009-08-17       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.